Stay updated on Tildrakizumab Long-Term Extension in Psoriatic Arthritis Clinical Trial

Sign up to get notified when there's something new on the Tildrakizumab Long-Term Extension in Psoriatic Arthritis Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Tildrakizumab Long-Term Extension in Psoriatic Arthritis Clinical Trial page

  1. Check
    5 days ago
    No Change Detected
  2. Check
    12 days ago
    No Change Detected
  3. Check
    19 days ago
    Change Detected
    Summary
    Updated the study locations to include new sites in the United States (Arizona, Colorado, Kansas, Kentucky, Louisiana, New Hampshire, North Carolina, Ohio, Tennessee, Washington) and international sites (Buenos Aires, Mexico City, Nuevo León, San Luis Potosí, Sinaloa, Yucatán, Lesser Poland Voivodeship, Kemerovo Oblast, Novosibirsk Oblast, Tomsk Oblast, La Coruna, Malaga, Vizcaya). Some locations that appeared in the previous revision were removed.
    Difference
    2%
    Check dated 2025-12-24T14:12:44.000Z thumbnail image
  4. Check
    27 days ago
    No Change Detected
  5. Check
    48 days ago
    Change Detected
    Summary
    Revision: v3.3.2 was added and v3.2.0 was removed. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.0%
    Check dated 2025-11-25T13:39:33.000Z thumbnail image
  6. Check
    56 days ago
    Change Detected
    Summary
    Removed the government funding lapse notice about potential delays; the page’s essential study information (eligibility criteria, locations, and treatment arms) remains unchanged. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.2%
    Check dated 2025-11-18T07:19:33.000Z thumbnail image
  7. Check
    70 days ago
    Change Detected
    Summary
    The updates are minor UI/layout adjustments and small textual edits on the Study Details page. Core information such as the study title, NCT number, condition, intervention, and listed locations remains unchanged.
    Difference
    0.3%
    Check dated 2025-11-03T21:19:05.000Z thumbnail image
  8. Check
    99 days ago
    Change Detected
    Summary
    Core content updated: a government funding and operating status notice has been added and the version updated to v3.2.0; the prior v3.1.0 tag was removed.
    Difference
    4%
    Check dated 2025-10-06T07:00:44.000Z thumbnail image
  9. Check
    106 days ago
    Change Detected
    Summary
    - Updated version from v3.0.2 to v3.1.0. - No other content changes detected.
    Difference
    0.1%
    Check dated 2025-09-29T03:51:05.000Z thumbnail image

Stay in the know with updates to Tildrakizumab Long-Term Extension in Psoriatic Arthritis Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Tildrakizumab Long-Term Extension in Psoriatic Arthritis Clinical Trial page.